Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Author

Zeng-Nan Mo

h-index 6 View on Semantic Scholar

We have 4 of 45 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Insulin resistance and uric acid-related metabolic disturbances jointly identify individuals at high risk of advanced cardiovascular-kidney-metabolic syndrome: a population-based study

Background Cardiovascular-kidney-metabolic (CKM) syndrome encompasses metabolic abnormalities, chronic kidney disease, and cardiovascular disease. The triglyceride–glucose (TyG) index reflects insulin resistance-related glucose–lipid imbalance, whereas serum uric acid (SUA) reflects purine metabolism and renal urate ha...

Sheng-Zhu Huang, Jing-Wei Lin, Ling-Yu Ye et al. · 0 citations
Open access Jul 2026

Environmental exposome study for prostate cancer in elderly men from Western China: preliminary findings from a case–control study in the WeEndPd cohort

Exposure to SO2 and specific EDCs (both individually and as a mixture) is significantly associated with localised PCa, and weighted quantile sum regression analysis demonstrated a significant positive association between the mixture of EDCs and PCa risk.

Xianghong Zhou, Yuchong He, Yumin Jin et al. · 0 citations
Open access Jul 2026

Single‐Cell Dissection of Therapy‐Induced Remodeling Uncovers a Fibroblast‐Driven Immunosuppressive Niche and Targetable Vulnerabilities in Lethal Prostate Cancer

These findings defined the DPT+‐complement‐macrophage axis as an actionable vulnerability and position TSPAN1 and NRXN1 as therapeutic entry points to disrupt ADT‐driven tumor ecosystem remodeling in prostate cancer.

Yang Chen, Dandan Dong, Jin-Ling Liao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.